Replies to post #372 on Merck and Co Inc (MRK)

[DewDiligence]

FDA approves Keytruda monotherapy in adjuvant melanoma with lymph-node involvement:

https://www.businesswire.com/news/home/20190219005210/en/FDA-Approves-Merck%E2%80%99s-KEYTRUDA%C2%AE-pembrolizumab-Adjuvant-Treatment